SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-10 - Registration Statement for Securities of certain Canadian Issuers.:
SEC Accession No. 0001062993-15-003131
Filing Date
2015-05-29
Accepted
2015-05-29 14:01:35
Documents
7

Document Format Files

Seq Description Document Type Size
1 FORM F-10 formf10.htm F-10 147119
2 EXHIBIT 4.2 exhibit4-2.htm EX-4.2 505199
3 EXHIBIT 5.1 exhibit5-1.htm EX-5.1 1353
4 GRAPHIC exhibit99-1x1x1.jpg GRAPHIC 5607
5 GRAPHIC exhibit99-1x6x1.jpg GRAPHIC 5622
6 GRAPHIC exhibit99-1x39x1.jpg GRAPHIC 27506
7 GRAPHIC prospectusx1x1.jpg GRAPHIC 3146
  Complete submission text file 0001062993-15-003131.txt   712920
Mailing Address 96 SKYWAY AVENUE TORONTO A6 M9W 4Y9
Business Address 96 SKYWAY AVENUE TORONTO A6 M9W 4Y9 (416) 595-0627
Trillium Therapeutics Inc. (Filer) CIK: 0001616212 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1214
Type: F-10 | Act: 33 | File No.: 333-204551 | Film No.: 15898687
SIC: 2834 Pharmaceutical Preparations